INMD InMode Ltd. logo

INMD InMode Ltd.

Healthcare
$13.79+0.00%OpenMarket Cap: $873.4M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

9.14

PEG

P/B

1.32

P/S

2.32

EV/EBITDA

4.88

DCF Value

$33.08

FCF Yield

10.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

77.8%

Operating Margin

21.3%

Net Margin

23.3%

ROE

13.3%

ROA

11.6%

ROIC

10.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$82.0M$11.6M$
Q4 null$103.9M$27.0M$
FY null$370.5M$93.8M$
Q3 null$93.2M$21.9M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$17.00

Target (Median)

$17.00

Target Range

$15.00 - $19.00

1 Strong Buy0 Buy5 Hold0 Sell0 Strong Sell
BairdNeutral
2026-05-07
BarclaysOverweight
2026-05-07
Canaccord GenuityHold
2025-12-17
UBSNeutral
2025-11-06
Canaccord GenuityHold
2025-10-10

Trading Activity

Insider Trades

View All
Mizrahy Moshedirector, officer: Chief Executive Officer
SellWed Mar 18
Malca Yairofficer: Chief Financial Officer
SellWed Mar 18
Malca Yairofficer: Chief Financial Officer
SellWed Mar 18
Malca Yairofficer: Chief Financial Officer
SellWed Mar 18
Kreindel Michaeldirector, officer: Chief Technology Officer
SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

IL

Exchange

Beta

1.98

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Peers